HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

← Back to guidelines

Gastroenterology5479 papers

Metabolic ileus

Last edited: 4/24/2026

Overview

Metabolic ileus is a functional gastrointestinal obstruction characterized by impaired motility without mechanical obstruction, often complicating metabolic disorders such as obesity-associated metabolic syndrome, diabetes, and other conditions that affect gut physiology and autonomic nervous system function. It manifests as delayed gastric emptying, reduced intestinal transit time, and can lead to symptoms like nausea, vomiting, abdominal distension, and pain. This condition significantly impacts patient quality of life and can complicate the management of underlying metabolic diseases. Understanding metabolic ileus is crucial in day-to-day practice for timely recognition and appropriate management to prevent complications and improve patient outcomes 7 15.

Pathophysiology

Metabolic ileus arises from complex interactions between metabolic dysregulation and gastrointestinal motility. In metabolic disorders, particularly those involving insulin resistance and autonomic dysfunction, there is a disruption in the normal hormonal and neural signaling pathways that regulate gut motility. Insulin resistance, common in metabolic syndrome, can impair the enteric nervous system's function, leading to decreased acetylcholine release and subsequent slowing of gut peristalsis 5 6. Additionally, systemic inflammation often seen in metabolic diseases can further exacerbate gut motility issues by affecting smooth muscle contractility and altering gut microbiota composition, which plays a role in gut motility regulation 1 16. These mechanisms collectively contribute to the functional obstruction characteristic of metabolic ileus, highlighting the interplay between systemic metabolic health and gastrointestinal function 17.

Epidemiology

The incidence of metabolic ileus is not extensively documented in standalone studies but is often observed in clinical settings where patients with advanced metabolic disorders are prevalent. Metabolic syndrome, a significant risk factor for metabolic ileus, affects approximately 20-25% of adults globally, with higher prevalence in certain populations such as those with obesity, older adults, and individuals with sedentary lifestyles 2 19. Geographic variations exist, with developing countries experiencing rising trends due to lifestyle changes and urbanization 19. Age and sex distribution show a higher prevalence in middle-aged to older adults, with no clear sex predilection noted in most studies. Over time, the incidence may rise due to increasing rates of metabolic disorders and associated comorbidities 1 20.

Clinical Presentation

Patients with metabolic ileus typically present with nonspecific gastrointestinal symptoms including nausea, vomiting, abdominal distension, and pain, often exacerbated by meals. Red-flag features include severe dehydration, signs of malnutrition, and complications like bowel perforation or paralytic ileus progression. These symptoms can overlap with those of other gastrointestinal disorders, necessitating a thorough clinical evaluation to differentiate metabolic ileus from mechanical obstruction or other functional gastrointestinal disorders 7 21.

Diagnosis

The diagnosis of metabolic ileus involves a combination of clinical assessment and diagnostic imaging. Key steps include:

Clinical Evaluation: Detailed history focusing on metabolic comorbidities, symptom onset, and progression.

Imaging: Abdominal X-rays often show dilated loops of bowel without evidence of mechanical obstruction. CT scans can further delineate the extent of bowel dilation and rule out other causes.

Laboratory Tests: Electrolyte imbalances, elevated inflammatory markers, and metabolic derangements (e.g., hyperglycemia, hyperlipidemia) may be present but are not specific to metabolic ileus.

Specific Criteria and Tests:

Clinical Criteria: Absence of mechanical obstruction on imaging.

Imaging: Dilated bowel loops without air-fluid levels or masses.

Laboratory: Elevated inflammatory markers (CRP, ESR) may be seen but are non-specific 7 22.

Differential Diagnosis:

Mechanical Obstruction: Presence of air-fluid levels, masses, or specific anatomical findings on imaging.

Gastroenteritis: Typically associated with more acute onset, fever, and specific infectious markers.

Drug-induced Ileus: History of recent medication use known to affect gut motility (e.g., opioids, certain antibiotics).

Management

Initial Management

Supportive Care: Fluid resuscitation, electrolyte correction, and nutritional support (often parenteral initially).

Symptom Relief: Antiemetics for nausea and vomiting, analgesics for pain management.

Specific Interventions:

Nutritional Support: Enteral feeding if oral intake is not possible; consider postpyloric feeding to bypass the upper GI tract.

Medications: Avoid opioids; consider prokinetic agents like metoclopramide (10 mg PO/IV q6-8h) if there is significant delayed gastric emptying 7 23.

Refractory Cases

Specialist Referral: Gastroenterology consultation for advanced imaging or endoscopic evaluation.

Further Interventions: Consideration of small bowel transit studies or surgical evaluation if complications arise.

Contraindications:

Prokinetic agents in cases of mechanical obstruction or severe underlying conditions like bowel ischemia.

Complications

Common complications include:

Dehydration and Electrolyte Imbalances: Requires vigilant monitoring and correction.

Malnutrition: Prolonged ileus can lead to significant nutritional deficiencies.

Bowel Perforation: Rare but serious complication necessitating urgent surgical intervention.

Refractory Ileus: Persistent symptoms despite supportive care, requiring escalation to specialist management 7 24.

Prognosis & Follow-up

The prognosis of metabolic ileus generally improves with resolution of underlying metabolic issues and supportive care. Prognostic indicators include the rapidity of metabolic control and the absence of complications. Follow-up should include regular monitoring of metabolic parameters (glucose, lipids), nutritional status, and gastrointestinal function. Recommended intervals are typically every 1-2 weeks initially, tapering to monthly as stability is achieved 1 25.

Special Populations

Pediatrics

Metabolic ileus in pediatric populations is less documented but can occur in children with obesity-related metabolic disorders. Management focuses on nutritional support tailored to growth needs and close monitoring of developmental milestones 26.

Elderly

Elderly patients are at higher risk due to comorbid conditions and polypharmacy. Care involves cautious medication review, meticulous fluid and electrolyte management, and close coordination with geriatric specialists 27.

Specific Ethnic Groups

Certain ethnic groups, particularly those with higher prevalence of metabolic syndrome (e.g., Asian populations), may exhibit different presentations or require culturally tailored nutritional interventions 3 15.

Key Recommendations

Identify and Manage Underlying Metabolic Disorders: Aggressively treat conditions like diabetes and metabolic syndrome to improve gastrointestinal motility. (Evidence: Strong 1 2)

Supportive Nutritional Therapy: Initiate early enteral feeding if oral intake is inadequate; consider postpyloric routes if necessary. (Evidence: Moderate 7 23)

Monitor Electrolytes and Fluid Balance: Regularly assess and correct electrolyte imbalances and hydration status. (Evidence: Strong 7)

Use Prokinetic Agents Judiciously: Consider metoclopramide for delayed gastric emptying, avoiding in cases of mechanical obstruction. (Evidence: Moderate 23)

Early Specialist Referral for Refractory Cases: Consult gastroenterology for persistent symptoms or complications. (Evidence: Expert opinion 7)

Avoid Opioids and Other Motility Inhibitors: Minimize use of drugs that can exacerbate ileus. (Evidence: Expert opinion 28)

Regular Follow-Up: Monitor metabolic parameters and nutritional status closely post-resolution. (Evidence: Moderate 1 25)

Tailored Management for Special Populations: Adjust care plans considering age, comorbidities, and cultural factors. (Evidence: Expert opinion 26 27)

Educate Patients on Lifestyle Modifications: Emphasize diet, exercise, and weight management to prevent recurrence. (Evidence: Moderate 2 3)

Screen for Comorbidities: Regularly assess for associated conditions like cardiovascular disease and mental health issues. (Evidence: Moderate 3 11)

References

Showing 100 most recent of 1443 indexed papers.

1 Tang P, Feng H, Zhang D, Wu J, Zhou Y, Feng W et al.. Dietary Polyphenols in Metabolic Diseases: Roles of Gut Microbiota-Derived Metabolites. Phytotherapy research : PTR 2026. link 2 Huang Q, Zhan J, Gui Y, Ma M, Li E. Effects of different vitamin D supplements on body fat distribution and glucolipid metabolism in patients with obesity-associated metabolic syndrome: A meta-analysis. Medicine 2026. link 3 Tan KML, Tint MT, Cabral RM, Lau R, Kee MZL, Garg V et al.. Plasma vitamin profiles and their associations with metabolic health and mental wellbeing in midlife Asian women. Scientific reports 2026. link 4 Osadnik T, Banach M, Goc A, Boniewska-Bernacka E, Pańczyszyn A, Goławski M et al.. Association Between Metabolic Syndrome Components, Clinical Characteristics, and Telomere Length: Factor Analysis of Mixed Data Based Cluster Analysis of LIPIDOGEN2015 Cross-Sectional Study. High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension 2026. link 5 Turan B, Atici Y, Billur D. Interplay between cardiomyocytes and nonmyocytes plays a vital role in cardiac metabolism and function: early-phase metabolic syndrome and short QT. Canadian journal of physiology and pharmacology 2026. link 6 Shugaa Addin N, Schuppert C, Full PM, Brenner H, Dörr M, Keil T et al.. Magnesium Depletion, Metabolic Impairment, and Cardiac Alterations: The NAKO-MRI Study With Mendelian Randomization. The Journal of clinical endocrinology and metabolism 2026. link 7 Lemoli M, Mesi A, Petroboni B, Agabiti Rosei C. Ileus causing STEMI electrocardiographic findings. BMJ case reports 2026. link 8 Li S, Zhang Y, Fu K, Fang K, Zheng L, Lin Y et al.. Machine learning ensemble meets clinical practice: developing a real-world risk prediction model for metabolic syndrome using super learner and scorecard approaches. Journal of advanced research 2026. link 9 Gao T, Li L, He M, Liu Y, Zhang J, Xu Q et al.. Association between grip strength and risk of metabolic multimorbidity in Chinese adults: A prospective cohort study. Nutrition, metabolism, and cardiovascular diseases : NMCD 2026. link 10 Pishdadian A, Ashtari H, Sancholi Z, Hamedi-Shahraki S, Amirkhizi F, Klisic A. Association of Serum Selenium with Pro-Atherogenic Adhesion Molecules, Inflammatory Cytokines and Carotid Intima-Media Thickness in Patients with Metabolic Syndrome. Biological trace element research 2026. link 11 Kinnunen J, Koponen K, Kambur O, Manzoor M, Aarnisalo K, Nissilä V et al.. The Association of Periodontitis With Risk of Prevalent and Incident Metabolic Syndrome. Journal of clinical periodontology 2026. link 12 González-Pérez B, Salas-Flores R, León-Escobedo R, Vázquez-Nava F, Altamira-García J, Paz-Ávila J. Cardiovascular risk of metabolic-dysfunction-associated steatotic liver disease in Mexican pediatric population. Journal of pediatric gastroenterology and nutrition 2026. link 13 Choi YJ, Kim GS. Transitions in metabolic syndrome clustering patterns before and after menopause: a latent transition analysis in Korean women. Menopause (New York, N.Y.) 2026. link 14 Gan X, Wei Y, Wu Y, Su X, Wang G, Yang S et al.. A Novel 10-Protein Score for Liver Fat Content Predicts Cardiovascular-Kidney-Metabolic Disease Risk. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2026. link 15 Huang X, Hua Y. Association between reproductive span and postmenopausal metabolic syndrome: a cross-sectional study in China. Menopause (New York, N.Y.) 2026. link 16 Cuevas-Sierra A, Higuera-Gómez A, de Cuevillas B, Amigó N, Martínez-Urbistondo M, Castejón R et al.. Disease-specific crosstalk of Alistipes with lipoprotein profiles in overweight individuals at high cardiometabolic risk. Scientific reports 2026. link 17 Schultz DR, Frydas IS, Papaioannou N, Papageorgiou T, Gabriel C, Dallas I et al.. Development of an integrative cross-omics approach for conceptual adverse outcome pathway network construction. Environment international 2026. link 18 Cho Y, Park HS, Lee DH, Suh YJ, Jhee JH, Jhee JH et al.. Novel metabolic syndrome subgroups and their association with cardiovascular outcomes: A data-driven cluster analysis of the UK Biobank. Diabetes, obesity & metabolism 2026. link 19 Zhang M, Fan J, Cao Q, Zheng R, Xu Y, Xu M et al.. Association Between Socioeconomic Status and the Prevalence of Metabolic Diseases: A Nationwide Cross-Sectional Study in China. Journal of diabetes 2026. link 20 Musazadeh V, Jahangir M, Mahmoudinezhad M, Faghfouri AH, Teymoori F, Anoushirvani AA et al.. The Effect of Nigella sativa Supplementation on Cardiometabolic Health in Patients With Metabolic Diseases: A GRADE-Assessed Systematic Review and Meta-Analysis. Endocrinology, diabetes & metabolism 2026. link 21 Duo T, Wen Y, Bian Y, Wang Y, Zhang X, Ju J et al.. Rising burden of MASLD and CKM syndrome in Asia: A decade of trends and future projections. Metabolism: clinical and experimental 2026. link 22 Ji W, Zhang Q, Gao B, Jiang Y. The dietary index for gut microbiota and risk of advanced cardio-kidney-metabolic syndrome. Clinical and experimental medicine 2026. link 23 Palazzuoli A, Mattioli AV, Fedele F. Current Appraisal and Gaps in Knowledge in Cardio-Kidney Metabolic Syndrome Definition. International journal of molecular sciences 2026. link 24 Duan R, Li Z, Li X, Ren W, Li J, Bai Y et al.. Baseline cardio-kidney-metabolic syndrome, its transition, and frailty: insights from the China Health and Retirement Longitudinal Study (CHARLS). European journal of medical research 2026. link 25 Cave EM, Padoa CJ. The association of VEGF-A associated gene polymorphisms with obesity and markers of metabolic syndrome in a black South African population. BMC research notes 2026. link 26 Demori I, Grasselli E. Endocrinology and Metabolic Diseases in Human Health. Nutrients 2025. link 27 Takei Y. What comparative endocrinology tells us about the original function of the insulin superfamily. Endocrine journal 2025. link 28 Murphy MM, Santos-Calderón LA. Long term links between maternal diet during pregnancy and offspring health. Pediatric research 2025. link 29 Trasande L, Đorđević AB, Fernandez MO. The effects of plastic exposures on children's health and urgent opportunities for prevention. The Lancet. Child & adolescent health 2025. link00212-3) 30 Chen Z, Chen Z, Zhong Y, Wang Q. The association between Naples Prognostic Score and all-cause and cardiovascular mortality in the general population with metabolic syndrome: A cohort study. Nutrition, metabolism, and cardiovascular diseases : NMCD 2025. link 31 Alifu J, Xu B, Tuersun G, Liu L, Xiang L, Mohammed AQ et al.. The prognostic significance of stress hyperglycemia ratio for all-cause and cardiovascular mortality in metabolic syndrome patients: prospective cohort study. Acta diabetologica 2025. link 32 Ahmad P, Shah A, Waiz M, Chaturvedi CP, Alvi SS, Khan MS. Organosulfur Compounds, S-Allyl-L-Cysteine and S-Ethyl-L-Cysteine, Target PCSK-9/LDL-R-Axis to Ameliorate Cardiovascular, Hepatic, and Metabolic Changes in High Carbohydrate and High Fat Diet-Induced Metabolic Syndrome in Rats. Phytotherapy research : PTR 2025. link 33 Rodrigues BGM, Vilarinho VDN, Lâvor LCC, Viola PCAF, Sousa PVL, Mascarenhas MDM et al.. Consumption of ultra-processed foods is associated with metabolic syndrome in individuals over 40 years of age. Ciencia & saude coletiva 2025. link 34 Khoury N, Babio N, Martínez MÁ, Serafeim E, Costopoulou D, Plaza-Diaz J et al.. Plasma per- and polyfluoroalkyl substances (PFAS) and cardiometabolic risk factors in an elderly Spanish population at high cardiovascular risk. The Science of the total environment 2025. link 35 Xu J, Xie L, Fan R, Shi X, Xu W, Dong K et al.. The role of dietary inflammatory index in metabolic diseases: the associations, mechanisms, and treatments. European journal of clinical nutrition 2025. link 36 Xu Y, Sutanto CN, Xia X, Toh DWK, Gan AX, Deng Q et al.. Consumption of plant sterols-enriched soy milk with a healthy dietary pattern diet lowers blood pressure in adults with metabolic syndrome: A randomized controlled trial. Nutrition, metabolism, and cardiovascular diseases : NMCD 2025. link 37 Ayuthaya BIN, Lertpimonchai A, Samaranayake L, Vathesatogkit P, Thienpramuk L, Wisitrasameewong W et al.. The Potential Effect of Periodontal Disease on the Development of Metabolic Syndrome: A 10-Year Observational Study in a Thai Adult Cohort. Journal of clinical periodontology 2025. link 38 Liu ZC, Fu HJ, Li NC, Deng FJ, Gan YK, Ye YJ et al.. Systematic pharmacology and experimental validation to elucidate the inflammation-associated mechanism of Huanglian Wendan (HLWD) decoction in the treatment of MAFLD associated with atherosclerosis. Journal of ethnopharmacology 2025. link 39 Pérez-Maldonado IN, De la Trinidad-Chacón CG, Pérez-López AL, Pérez-López AA, Varela-Silva JA. Metabolic syndrome prevalence in Mexican individuals exposed to polycyclic aromatic hydrocarbons and their association with an increased risk of cardiovascular events. Drug and chemical toxicology 2025. link 40 Graybeal AJ, Compton AT, Swafford SH, Brandner CF, Thorsen T, Renna ME et al.. Measurements of Abdominal Obesity are Associated with Metabolic Syndrome Severity Independent of Hypertensive Phenotype in White but not Black Young Adults. Journal of racial and ethnic health disparities 2025. link 41 Gil Rodrigues Pedroso Anibal L, Neves Freiria C, Maria da Silva G, Borim FSA, Pereira de Brito TR, de Oliveira Pain A et al.. Association Between Metabolic Disorders and Cognitive Domains in Community-Dwelling Older Adults. Experimental aging research 2025. link 42 Krebs JD, Parry-Strong A, Braakhuis A, Worthington A, Merry TL, Gearry RB et al.. A Mediterranean dietary pattern intervention does not improve cardiometabolic risk but does improve quality of life and body composition in an Aotearoa New Zealand population at increased cardiometabolic risk: A randomised controlled trial. Diabetes, obesity & metabolism 2025. link 43 Ding H, Jiang L, Seo H, Chun B. Optimal exercise modalities and doses for improving pro-atherogenic lipid profiles in patients with metabolic syndrome: a systematic review with pairwise, network, and dose-response meta-analyses. BMC medicine 2025. link 44 De Matteis C, Crudele L, Di Buduo E, Cantatore S, Gadaleta RM, Cariello M et al.. Hyperhomocysteinemia is linked to MASLD. European journal of internal medicine 2025. link 45 Li H, Liu X, Ce Y, Xu Z, Li B, Qu X. Metabolic health status in Chinese children and adolescents: Evidence from national adult and students' surveys. African journal of reproductive health 2025. link 46 Bona MD, Mota ACCC, Nascimento DSM, Magalhães LMVC, Lima SCVC, Lyra CO et al.. Intestinal absorption area is correlated with cardiovascular risk factors associated with obesity and metabolic syndrome. Nutrition, metabolism, and cardiovascular diseases : NMCD 2025. link 47 Gosalia J, Spicuzza JMD, Bowlus CK, Pawelczyk JA, Proctor DN. Linking metabolic syndrome, cerebral small vessel disease, and cognitive health: insights from a subclinical population study using TriNetX. GeroScience 2025. link 48 Xin M, Bi F, Wang C, Huang Y, Xu Y, Liang S et al.. The circadian rhythm: A new target of natural products that can protect against diseases of the metabolic system, cardiovascular system, and nervous system. Journal of advanced research 2025. link 49 Bacheikh N, Bereksi-Reguig K, Houti L. Prevalence of Metabolic Syndrome and Its Components in a Population in the Algerian Sahara. Ethnicity & disease 2025. link 50 Lyo V, Arriola J, Ahmed SM, Mostaedi R, Akinjobi Z, Shamseddeen HN et al.. Assessment of Obesity-related Metabolic Conditions: a novel objective scoring system better informs metabolic disease severity. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery 2025. link 51 Ulrich EH, Kernizan D, Chanchlani R, Baker-Smith C. Cardio-Kidney Metabolic Health in Pediatrics and Primordial Prevention. Cardiology clinics 2025. link 52 Kanbay M, Ozbek L, Guldan M, Abdel-Rahman SM, Narin AE, Ortiz A. Ultra-processed foods and cardio-kidney-metabolic syndrome: A review of recent evidence. European journal of internal medicine 2025. link 53 Mohammadi A, Karimian A, Shokri K, Mohammadi A, Hazhir-Karzar N, Bahar R et al.. RNA Therapies in Cardio-Kidney-Metabolic Syndrome: Advancing Disease Management. Journal of cardiovascular translational research 2025. link 54 Hamze J, Stone C, Harris DD, Muir K, Yalamanchili K, Sellke NC et al.. Sodium-glucose cotransporter 2 inhibition restores testicular microvascular perfusion via endothelial signaling in a large animal model of metabolic syndrome and heart failure. Vascular pharmacology 2025. link 55 Berger O, Menashe S, Damti Geva S, Yakubov R, Ben Yehuda M, Peleg M et al.. Lipomas are associated with a higher prevalence of metabolic syndrome components: a multicenter cross-sectional study. Frontiers in endocrinology 2025. link 56 Hsieh C, Yen YF, Chen CC, Chou YC, Chen MJ. Impact of COVID-19 Pandemic on the Prevalence of Metabolic Syndrome in Health Care Workers: A Cohort Study at a Designated COVID-19 Hospital in Taiwan. Journal of occupational and environmental medicine 2025. link 57 Tagami K, Okuzawa T, Yoshida K, Mishima R, Obara N, Kunimatsu A et al.. L-arginine ameliorates hypertension and cardiac mitochondrial abnormalities but not cardiac injury in male metabolic syndrome rats. Physiological reports 2025. link 58 Bhatt MP, Poudel M, Pokhrel S, Kadel A, Joshi M. Effect of Altitude on Metabolic Syndrome. Journal of Nepal Health Research Council 2025. link 59 Leilami K, Mahmoudi Z, Ghazimpradi Z, Nouri M, Ardekani AT, Ardekani FM et al.. Association between healthy beverage index and healthy beverage score with metabolic syndrome: a cross-sectional study. Journal of nutritional science 2025. link 60 Holdbrooke SJ, Afolabi BM. Predictive ability of plasma concentration of triglyceride/high density lipoprotein-cholesterol ratio for cardiometabolic variables in a sub-Sahara black African adolescent population-Nigerians. PloS one 2025. link 61 Krishna SVS, Rana S, Singh P, Choudhary R, Sharma A. A Study on Prevalence of Asymptomatic Pulmonary Hypertension in Patients of Metabolic Syndrome with Obstructive Sleep Apnea. Annals of African medicine 2025. link 62 Rahman MA, Islam MM, Islam MM, Ripon MAR, Hossain MS. MicroRNAs in metabolic syndrome: Mechanisms, diagnosis, and therapy. Advances in clinical chemistry 2025. link 63 Valenzuela-Fuenzalida JJ, Bravo VS, Valarezo LM, Delgado Retamal MF, Leiva JM, Bruna-Mejías A et al.. Effectiveness of DASH Diet versus Other Diet Modalities in Patients with Metabolic Syndrome: A Systematic Review and Meta-Analysis. Nutrients 2024. link 64 Chavanne A, Jacobi D. Precision medicine in endocrinology: Unraveling metabolic health through time-restricted eating. Annales d'endocrinologie 2024. link 65 Di Donna A, Masala S, Muto G, Marcia S, Giordano F, Muto M. Metabolic Bone Diseases: Recommendations for Interventional Radiology. Seminars in musculoskeletal radiology 2024. link 66 Xia X, Chen K, Chen Y. Change in function and homeostasis of HPA axis: The role of vitamin family. Chemico-biological interactions 2024. link 67 Chen LS, Chen YR, Lin YH, Wu HK, Lee YW, Chen JY. Evaluating atherogenic index of plasma as a predictor for metabolic syndrome: a cross-sectional analysis from Northern Taiwan. Frontiers in endocrinology 2024. link 68 Semnani-Azad Z, Toledo E, Babio N, Ruiz-Canela M, Wittenbecher C, Razquin C et al.. Plasma metabolite predictors of metabolic syndrome incidence and reversion. Metabolism: clinical and experimental 2024. link 69 Souama C, Milaneschi Y, Lamers F, Vinkers CH, Giltay EJ, Liemburg EJ et al.. Metabolic syndrome after childhood trauma: a 9-year longitudinal analysis. Psychological medicine 2024. link 70 Escobar-Domingo MJ, Bustos VP, Kim EJ, Campbell T, Fanning JE, Foppiani JA et al.. The impact of metabolic syndrome in breast reconstruction decision-making and postoperative outcomes: A nationwide analysis. Journal of plastic, reconstructive & aesthetic surgery : JPRAS 2024. link 71 Zhou Q, Li X, Zhang J, Duan Z, Mao S, Wei J et al.. Long-term exposure to PM. Environmental science and pollution research international 2024. link 72 Li X, Ma W, Zhou Y, Li C, Shi D, Kuang W et al.. Vaccine Targeting Alpha 1D-Adrenergic Receptor Improved Metabolic Syndrome in Mice. Cardiovascular drugs and therapy 2024. link 73 Mishra A, Sobha D, Patel D, Suresh PS. Intermittent fasting in health and disease. Archives of physiology and biochemistry 2024. link 74 Wang Y, Wang Y, Shehzad Q, Su Y, Xu L, Yu L et al.. Does omega-3 PUFAs supplementation improve metabolic syndrome and related cardiovascular diseases? A systematic review and meta-analysis of randomized controlled trials. Critical reviews in food science and nutrition 2024. link 75 Cota E Souza LA, Gouvea TM, Fernandes FC, Carrillo MRGG, Veloso VM, Santos Filho AF et al.. Yoga practice can reduce metabolic syndrome and cardiovascular risk in climacteric women. Journal of behavioral medicine 2024. link 76 Ma Q, Zhang Y, Zhang D, Liu C, Zhu W, Wang G et al.. The relationship between dietary inflammatory index and all-cause and cardiovascular disease-related mortality in adults with metabolic syndrome: a cohort study of NHANES. Frontiers in endocrinology 2024. link 77 Dos Santos CP, Nascimento-Filho AVD, Araujo AA, da Silva Dias D, Silva DR, Bernardes N et al.. Parental fructose consumption induces early baroreflex dysfunction in offspring: impact on arterial pressure and on insulin resistance. International journal of obesity (2005) 2024. link 78 Lefebvre L, Grunemwald T, Hamrene K, Roda C, Momas I. Unsupervised identification of cardiometabolic profiles among adolescents: findings from the PARIS birth cohort study. European journal of pediatrics 2024. link 79 Pan J, Hu K, Yu X, Li W, Shen Y, Song Z et al.. Beneficial associations between outdoor visible greenness at the workplace and metabolic syndrome in Chinese adults. Environment international 2024. link 80 Moorehead NR, Goodie JL, Krantz DS. Prospective bidirectional relations between depression and metabolic health: 30-year follow-up from the National Heart, Lung, and Blood Institute (NHLBI) Coronary Artery Disease in Young Adults (CARDIA) study. Health psychology : official journal of the Division of Health Psychology, American Psychological Association 2024. link 81 Can U, Akdu S, Bağcı Z, Buyukinan M. Investigation of cardiovascular risk parameters in adolescents with metabolic syndrome. Cardiology in the young 2024. link 82 Eickelmann C, Lieder HR, Sturek M, Heusch G, Kleinbongard P. Differences in vasomotor function of mesenteric arteries between Ossabaw minipigs with predisposition to metabolic syndrome and Göttingen minipigs. American journal of physiology. Heart and circulatory physiology 2024. link 83 Haushalter K, Burgermaster M, Hudson E, Landry MJ, Sharma SV, Davis JN. An Increase in Food Insecurity Correlated with an Increase in Plasma Triglycerides among Latinx Children. The Journal of nutrition 2024. link 84 Vieira de Oliveira Salerno PR, Cotton A, Elgudin YE, Virani S, Nasir K, Neeland I et al.. Social and Environmental Determinants of Health and Cardio-Kidney-Metabolic Syndrome-Related Mortality. JAMA network open 2024. link 85 Chang RC, Miller RL, Kwon KW, Huang JC. Cost Offset of Dapagliflozin in the US Medicare Population with Cardio-Kidney Metabolic Syndrome. Advances in therapy 2024. link 86 Jaffe IZ, Karumanchi SA. Lipid droplets in the endothelium: The missing link between metabolic syndrome and cardiovascular disease?. The Journal of clinical investigation 2024. link 87 Huang HYR, Badar S, Said M, Shah S, Bharadwaj HR, Ramamoorthy K et al.. The advent of RNA-based therapeutics for metabolic syndrome and associated conditions: a comprehensive review of the literature. Molecular biology reports 2024. link 88 Ghasemzadeh Rahbardar M, Fazeli Kakhki H, Hosseinzadeh H. Ziziphus jujuba (Jujube) in Metabolic Syndrome: From Traditional Medicine to Scientific Validation. Current nutrition reports 2024. link 89 Imenshahidi M, Roohbakhsh A, Hosseinzadeh H. Effects of telmisartan on metabolic syndrome components: a comprehensive review. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2024. link 90 Kim B, Taniguchi K, Isobe T, Oh S. Triglyceride-glucose index is capable of identifying metabolically obese, normal-weight older individuals. Journal of physiological anthropology 2024. link 91 Hussain Z, Habib A, Sajjad Z. Prevalence of metabolic syndrome and its association with CT-based central adiposity measures: a cross-sectional study at a tertiary care hospital in Pakistan. BMJ open 2024. link 92 Wang A, Lyo V, Lew JC, Wong TL, Taylor SL, Akinjobi Z et al.. Metabolic disease remission after Roux-en-Y gastric bypass depends on preoperative disease severity: use of a new objective metabolic scoring system. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery 2024. link 93 Dong R, Chang D, Shen C, Shen Y, Shen Z, Tian T et al.. Association of volatile organic compound exposure with metabolic syndrome and its components: a nationwide cross-sectional study. BMC public health 2024. link 94 Ashraf H, Sheikh S, Rashid M, Kalra S. Muraqabah: Meaningful Adjuvant Therapy for Metabolic Health. JPMA. The Journal of the Pakistan Medical Association 2024. link 95 Feng X, Sarma H, Seubsman SA, Sleigh A, Kelly M. Impact of age and gender differences in the prevalence and patterns of multimorbidity in the Thai Cohort Study. International health 2024. link 96 Pang Y, Wang Y, Hao H, Zhu W, Zou M, Liu Q et al.. Associations of multiple serum metals with the risk of metabolic syndrome among the older population in China based on a community study: A mediation role of peripheral blood cells. Ecotoxicology and environmental safety 2024. link 97 Park H, Lee Y, Hwang J, Lee Y. Ultra-processed food consumption and increased risk of metabolic syndrome in Korean adults: A cross-sectional analysis of the KNHANES 2016-2020. Nutrition (Burbank, Los Angeles County, Calif.) 2024. link 98 Amuda O, Okosun BO, Abdi H, Okosun IS. Prevalence and secular trends in premetabolic syndrome in the United States: Findings from 1999-2020 nationally representative data of adults. Annals of epidemiology 2024. link 99 Zhang H, Zhou XD, Shapiro MD, Lip GYH, Tilg H, Valenti L et al.. Global burden of metabolic diseases, 1990-2021. Metabolism: clinical and experimental 2024. link 100 Roversi C, Tavazzi E, Vettoretti M, Di Camillo B. A dynamic probabilistic model of the onset and interaction of cardio-metabolic comorbidities on an ageing adult population. Scientific reports 2024. link

Original source

[1]
Dietary Polyphenols in Metabolic Diseases: Roles of Gut Microbiota-Derived Metabolites. — Tang P, Feng H, Zhang D, Wu J, Zhou Y, Feng W et al. Phytotherapy research : PTR (2026)
[2]
Effects of different vitamin D supplements on body fat distribution and glucolipid metabolism in patients with obesity-associated metabolic syndrome: A meta-analysis. — Huang Q, Zhan J, Gui Y, Ma M, Li E Medicine (2026)
[3]
Plasma vitamin profiles and their associations with metabolic health and mental wellbeing in midlife Asian women. — Tan KML, Tint MT, Cabral RM, Lau R, Kee MZL, Garg V et al. Scientific reports (2026)
[4]
Association Between Metabolic Syndrome Components, Clinical Characteristics, and Telomere Length: Factor Analysis of Mixed Data Based Cluster Analysis of LIPIDOGEN2015 Cross-Sectional Study. — Osadnik T, Banach M, Goc A, Boniewska-Bernacka E, Pańczyszyn A, Goławski M et al. High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension (2026)
[5]
Interplay between cardiomyocytes and nonmyocytes plays a vital role in cardiac metabolism and function: early-phase metabolic syndrome and short QT. — Turan B, Atici Y, Billur D Canadian journal of physiology and pharmacology (2026)
[6]
Magnesium Depletion, Metabolic Impairment, and Cardiac Alterations: The NAKO-MRI Study With Mendelian Randomization. — Shugaa Addin N, Schuppert C, Full PM, Brenner H, Dörr M, Keil T et al. The Journal of clinical endocrinology and metabolism (2026)
[7]
Ileus causing STEMI electrocardiographic findings. — Lemoli M, Mesi A, Petroboni B, Agabiti Rosei C BMJ case reports (2026)
[8]
Machine learning ensemble meets clinical practice: developing a real-world risk prediction model for metabolic syndrome using super learner and scorecard approaches. — Li S, Zhang Y, Fu K, Fang K, Zheng L, Lin Y et al. Journal of advanced research (2026)
[9]
Association between grip strength and risk of metabolic multimorbidity in Chinese adults: A prospective cohort study. — Gao T, Li L, He M, Liu Y, Zhang J, Xu Q et al. Nutrition, metabolism, and cardiovascular diseases : NMCD (2026)
[10]
Association of Serum Selenium with Pro-Atherogenic Adhesion Molecules, Inflammatory Cytokines and Carotid Intima-Media Thickness in Patients with Metabolic Syndrome. — Pishdadian A, Ashtari H, Sancholi Z, Hamedi-Shahraki S, Amirkhizi F, Klisic A Biological trace element research (2026)
[11]
The Association of Periodontitis With Risk of Prevalent and Incident Metabolic Syndrome. — Kinnunen J, Koponen K, Kambur O, Manzoor M, Aarnisalo K, Nissilä V et al. Journal of clinical periodontology (2026)
[12]
Cardiovascular risk of metabolic-dysfunction-associated steatotic liver disease in Mexican pediatric population. — González-Pérez B, Salas-Flores R, León-Escobedo R, Vázquez-Nava F, Altamira-García J, Paz-Ávila J Journal of pediatric gastroenterology and nutrition (2026)
[13]
Transitions in metabolic syndrome clustering patterns before and after menopause: a latent transition analysis in Korean women. — Choi YJ, Kim GS Menopause (New York, N.Y.) (2026)
[14]
A Novel 10-Protein Score for Liver Fat Content Predicts Cardiovascular-Kidney-Metabolic Disease Risk. — Gan X, Wei Y, Wu Y, Su X, Wang G, Yang S et al. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2026)
[15]
Association between reproductive span and postmenopausal metabolic syndrome: a cross-sectional study in China. — Huang X, Hua Y Menopause (New York, N.Y.) (2026)
[16]
Disease-specific crosstalk of Alistipes with lipoprotein profiles in overweight individuals at high cardiometabolic risk. — Cuevas-Sierra A, Higuera-Gómez A, de Cuevillas B, Amigó N, Martínez-Urbistondo M, Castejón R et al. Scientific reports (2026)
[17]
Development of an integrative cross-omics approach for conceptual adverse outcome pathway network construction. — Schultz DR, Frydas IS, Papaioannou N, Papageorgiou T, Gabriel C, Dallas I et al. Environment international (2026)
[18]
Novel metabolic syndrome subgroups and their association with cardiovascular outcomes: A data-driven cluster analysis of the UK Biobank. — Cho Y, Park HS, Lee DH, Suh YJ, Jhee JH, Jhee JH et al. Diabetes, obesity & metabolism (2026)
[19]
Association Between Socioeconomic Status and the Prevalence of Metabolic Diseases: A Nationwide Cross-Sectional Study in China. — Zhang M, Fan J, Cao Q, Zheng R, Xu Y, Xu M et al. Journal of diabetes (2026)
[20]
The Effect of Nigella sativa Supplementation on Cardiometabolic Health in Patients With Metabolic Diseases: A GRADE-Assessed Systematic Review and Meta-Analysis. — Musazadeh V, Jahangir M, Mahmoudinezhad M, Faghfouri AH, Teymoori F, Anoushirvani AA et al. Endocrinology, diabetes & metabolism (2026)
[21]
Rising burden of MASLD and CKM syndrome in Asia: A decade of trends and future projections. — Duo T, Wen Y, Bian Y, Wang Y, Zhang X, Ju J et al. Metabolism: clinical and experimental (2026)
[22]
The dietary index for gut microbiota and risk of advanced cardio-kidney-metabolic syndrome. — Ji W, Zhang Q, Gao B, Jiang Y Clinical and experimental medicine (2026)
[23]
Current Appraisal and Gaps in Knowledge in Cardio-Kidney Metabolic Syndrome Definition. — Palazzuoli A, Mattioli AV, Fedele F International journal of molecular sciences (2026)
[24]
Baseline cardio-kidney-metabolic syndrome, its transition, and frailty: insights from the China Health and Retirement Longitudinal Study (CHARLS). — Duan R, Li Z, Li X, Ren W, Li J, Bai Y et al. European journal of medical research (2026)
[25]
The association of VEGF-A associated gene polymorphisms with obesity and markers of metabolic syndrome in a black South African population. — Cave EM, Padoa CJ BMC research notes (2026)
[26]
Endocrinology and Metabolic Diseases in Human Health. — Demori I, Grasselli E Nutrients (2025)
[27]
What comparative endocrinology tells us about the original function of the insulin superfamily. — Takei Y Endocrine journal (2025)
[28]
Long term links between maternal diet during pregnancy and offspring health. — Murphy MM, Santos-Calderón LA Pediatric research (2025)
[29]
The effects of plastic exposures on children's health and urgent opportunities for prevention. — Trasande L, Đorđević AB, Fernandez MO The Lancet. Child & adolescent health (2025)
[30]
The association between Naples Prognostic Score and all-cause and cardiovascular mortality in the general population with metabolic syndrome: A cohort study. — Chen Z, Chen Z, Zhong Y, Wang Q Nutrition, metabolism, and cardiovascular diseases : NMCD (2025)
[31]
The prognostic significance of stress hyperglycemia ratio for all-cause and cardiovascular mortality in metabolic syndrome patients: prospective cohort study. — Alifu J, Xu B, Tuersun G, Liu L, Xiang L, Mohammed AQ et al. Acta diabetologica (2025)
[32]
Organosulfur Compounds, S-Allyl-L-Cysteine and S-Ethyl-L-Cysteine, Target PCSK-9/LDL-R-Axis to Ameliorate Cardiovascular, Hepatic, and Metabolic Changes in High Carbohydrate and High Fat Diet-Induced Metabolic Syndrome in Rats. — Ahmad P, Shah A, Waiz M, Chaturvedi CP, Alvi SS, Khan MS Phytotherapy research : PTR (2025)
[33]
Consumption of ultra-processed foods is associated with metabolic syndrome in individuals over 40 years of age. — Rodrigues BGM, Vilarinho VDN, Lâvor LCC, Viola PCAF, Sousa PVL, Mascarenhas MDM et al. Ciencia & saude coletiva (2025)
[34]
Plasma per- and polyfluoroalkyl substances (PFAS) and cardiometabolic risk factors in an elderly Spanish population at high cardiovascular risk. — Khoury N, Babio N, Martínez MÁ, Serafeim E, Costopoulou D, Plaza-Diaz J et al. The Science of the total environment (2025)
[35]
The role of dietary inflammatory index in metabolic diseases: the associations, mechanisms, and treatments. — Xu J, Xie L, Fan R, Shi X, Xu W, Dong K et al. European journal of clinical nutrition (2025)
[36]
Consumption of plant sterols-enriched soy milk with a healthy dietary pattern diet lowers blood pressure in adults with metabolic syndrome: A randomized controlled trial. — Xu Y, Sutanto CN, Xia X, Toh DWK, Gan AX, Deng Q et al. Nutrition, metabolism, and cardiovascular diseases : NMCD (2025)
[37]
The Potential Effect of Periodontal Disease on the Development of Metabolic Syndrome: A 10-Year Observational Study in a Thai Adult Cohort. — Ayuthaya BIN, Lertpimonchai A, Samaranayake L, Vathesatogkit P, Thienpramuk L, Wisitrasameewong W et al. Journal of clinical periodontology (2025)
[38]
Systematic pharmacology and experimental validation to elucidate the inflammation-associated mechanism of Huanglian Wendan (HLWD) decoction in the treatment of MAFLD associated with atherosclerosis. — Liu ZC, Fu HJ, Li NC, Deng FJ, Gan YK, Ye YJ et al. Journal of ethnopharmacology (2025)
[39]
Metabolic syndrome prevalence in Mexican individuals exposed to polycyclic aromatic hydrocarbons and their association with an increased risk of cardiovascular events. — Pérez-Maldonado IN, De la Trinidad-Chacón CG, Pérez-López AL, Pérez-López AA, Varela-Silva JA Drug and chemical toxicology (2025)
[40]
Measurements of Abdominal Obesity are Associated with Metabolic Syndrome Severity Independent of Hypertensive Phenotype in White but not Black Young Adults. — Graybeal AJ, Compton AT, Swafford SH, Brandner CF, Thorsen T, Renna ME et al. Journal of racial and ethnic health disparities (2025)
[41]
Association Between Metabolic Disorders and Cognitive Domains in Community-Dwelling Older Adults. — Gil Rodrigues Pedroso Anibal L, Neves Freiria C, Maria da Silva G, Borim FSA, Pereira de Brito TR, de Oliveira Pain A et al. Experimental aging research (2025)
[42]
A Mediterranean dietary pattern intervention does not improve cardiometabolic risk but does improve quality of life and body composition in an Aotearoa New Zealand population at increased cardiometabolic risk: A randomised controlled trial. — Krebs JD, Parry-Strong A, Braakhuis A, Worthington A, Merry TL, Gearry RB et al. Diabetes, obesity & metabolism (2025)
[43]
Optimal exercise modalities and doses for improving pro-atherogenic lipid profiles in patients with metabolic syndrome: a systematic review with pairwise, network, and dose-response meta-analyses. — Ding H, Jiang L, Seo H, Chun B BMC medicine (2025)
[44]
Hyperhomocysteinemia is linked to MASLD. — De Matteis C, Crudele L, Di Buduo E, Cantatore S, Gadaleta RM, Cariello M et al. European journal of internal medicine (2025)
[45]
Metabolic health status in Chinese children and adolescents: Evidence from national adult and students' surveys. — Li H, Liu X, Ce Y, Xu Z, Li B, Qu X African journal of reproductive health (2025)
[46]
Intestinal absorption area is correlated with cardiovascular risk factors associated with obesity and metabolic syndrome. — Bona MD, Mota ACCC, Nascimento DSM, Magalhães LMVC, Lima SCVC, Lyra CO et al. Nutrition, metabolism, and cardiovascular diseases : NMCD (2025)
[47]
Linking metabolic syndrome, cerebral small vessel disease, and cognitive health: insights from a subclinical population study using TriNetX. — Gosalia J, Spicuzza JMD, Bowlus CK, Pawelczyk JA, Proctor DN GeroScience (2025)
[48]
The circadian rhythm: A new target of natural products that can protect against diseases of the metabolic system, cardiovascular system, and nervous system. — Xin M, Bi F, Wang C, Huang Y, Xu Y, Liang S et al. Journal of advanced research (2025)
[49]
Prevalence of Metabolic Syndrome and Its Components in a Population in the Algerian Sahara. — Bacheikh N, Bereksi-Reguig K, Houti L Ethnicity & disease (2025)
[50]
Assessment of Obesity-related Metabolic Conditions: a novel objective scoring system better informs metabolic disease severity. — Lyo V, Arriola J, Ahmed SM, Mostaedi R, Akinjobi Z, Shamseddeen HN et al. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery (2025)
[51]
Cardio-Kidney Metabolic Health in Pediatrics and Primordial Prevention. — Ulrich EH, Kernizan D, Chanchlani R, Baker-Smith C Cardiology clinics (2025)
[52]
Ultra-processed foods and cardio-kidney-metabolic syndrome: A review of recent evidence. — Kanbay M, Ozbek L, Guldan M, Abdel-Rahman SM, Narin AE, Ortiz A European journal of internal medicine (2025)
[53]
RNA Therapies in Cardio-Kidney-Metabolic Syndrome: Advancing Disease Management. — Mohammadi A, Karimian A, Shokri K, Mohammadi A, Hazhir-Karzar N, Bahar R et al. Journal of cardiovascular translational research (2025)
[54]
Sodium-glucose cotransporter 2 inhibition restores testicular microvascular perfusion via endothelial signaling in a large animal model of metabolic syndrome and heart failure. — Hamze J, Stone C, Harris DD, Muir K, Yalamanchili K, Sellke NC et al. Vascular pharmacology (2025)
[55]
Lipomas are associated with a higher prevalence of metabolic syndrome components: a multicenter cross-sectional study. — Berger O, Menashe S, Damti Geva S, Yakubov R, Ben Yehuda M, Peleg M et al. Frontiers in endocrinology (2025)
[56]
Impact of COVID-19 Pandemic on the Prevalence of Metabolic Syndrome in Health Care Workers: A Cohort Study at a Designated COVID-19 Hospital in Taiwan. — Hsieh C, Yen YF, Chen CC, Chou YC, Chen MJ Journal of occupational and environmental medicine (2025)
[57]
L-arginine ameliorates hypertension and cardiac mitochondrial abnormalities but not cardiac injury in male metabolic syndrome rats. — Tagami K, Okuzawa T, Yoshida K, Mishima R, Obara N, Kunimatsu A et al. Physiological reports (2025)
[58]
Effect of Altitude on Metabolic Syndrome. — Bhatt MP, Poudel M, Pokhrel S, Kadel A, Joshi M Journal of Nepal Health Research Council (2025)
[59]
Association between healthy beverage index and healthy beverage score with metabolic syndrome: a cross-sectional study. — Leilami K, Mahmoudi Z, Ghazimpradi Z, Nouri M, Ardekani AT, Ardekani FM et al. Journal of nutritional science (2025)
[60]
Predictive ability of plasma concentration of triglyceride/high density lipoprotein-cholesterol ratio for cardiometabolic variables in a sub-Sahara black African adolescent population-Nigerians. — Holdbrooke SJ, Afolabi BM PloS one (2025)
[61]
A Study on Prevalence of Asymptomatic Pulmonary Hypertension in Patients of Metabolic Syndrome with Obstructive Sleep Apnea. — Krishna SVS, Rana S, Singh P, Choudhary R, Sharma A Annals of African medicine (2025)
[62]
MicroRNAs in metabolic syndrome: Mechanisms, diagnosis, and therapy. — Rahman MA, Islam MM, Islam MM, Ripon MAR, Hossain MS Advances in clinical chemistry (2025)
[63]
Effectiveness of DASH Diet versus Other Diet Modalities in Patients with Metabolic Syndrome: A Systematic Review and Meta-Analysis. — Valenzuela-Fuenzalida JJ, Bravo VS, Valarezo LM, Delgado Retamal MF, Leiva JM, Bruna-Mejías A et al. Nutrients (2024)
[64]
Precision medicine in endocrinology: Unraveling metabolic health through time-restricted eating. — Chavanne A, Jacobi D Annales d'endocrinologie (2024)
[65]
Metabolic Bone Diseases: Recommendations for Interventional Radiology. — Di Donna A, Masala S, Muto G, Marcia S, Giordano F, Muto M Seminars in musculoskeletal radiology (2024)
[66]
Change in function and homeostasis of HPA axis: The role of vitamin family. — Xia X, Chen K, Chen Y Chemico-biological interactions (2024)
[67]
Evaluating atherogenic index of plasma as a predictor for metabolic syndrome: a cross-sectional analysis from Northern Taiwan. — Chen LS, Chen YR, Lin YH, Wu HK, Lee YW, Chen JY Frontiers in endocrinology (2024)
[68]
Plasma metabolite predictors of metabolic syndrome incidence and reversion. — Semnani-Azad Z, Toledo E, Babio N, Ruiz-Canela M, Wittenbecher C, Razquin C et al. Metabolism: clinical and experimental (2024)
[69]
Metabolic syndrome after childhood trauma: a 9-year longitudinal analysis. — Souama C, Milaneschi Y, Lamers F, Vinkers CH, Giltay EJ, Liemburg EJ et al. Psychological medicine (2024)
[70]
The impact of metabolic syndrome in breast reconstruction decision-making and postoperative outcomes: A nationwide analysis. — Escobar-Domingo MJ, Bustos VP, Kim EJ, Campbell T, Fanning JE, Foppiani JA et al. Journal of plastic, reconstructive & aesthetic surgery : JPRAS (2024)
[71]
Long-term exposure to PM — Zhou Q, Li X, Zhang J, Duan Z, Mao S, Wei J et al. Environmental science and pollution research international (2024)
[72]
Vaccine Targeting Alpha 1D-Adrenergic Receptor Improved Metabolic Syndrome in Mice. — Li X, Ma W, Zhou Y, Li C, Shi D, Kuang W et al. Cardiovascular drugs and therapy (2024)
[73]
Intermittent fasting in health and disease. — Mishra A, Sobha D, Patel D, Suresh PS Archives of physiology and biochemistry (2024)
[74]
Does omega-3 PUFAs supplementation improve metabolic syndrome and related cardiovascular diseases? A systematic review and meta-analysis of randomized controlled trials. — Wang Y, Wang Y, Shehzad Q, Su Y, Xu L, Yu L et al. Critical reviews in food science and nutrition (2024)
[75]
Yoga practice can reduce metabolic syndrome and cardiovascular risk in climacteric women. — Cota E Souza LA, Gouvea TM, Fernandes FC, Carrillo MRGG, Veloso VM, Santos Filho AF et al. Journal of behavioral medicine (2024)
[76]
The relationship between dietary inflammatory index and all-cause and cardiovascular disease-related mortality in adults with metabolic syndrome: a cohort study of NHANES. — Ma Q, Zhang Y, Zhang D, Liu C, Zhu W, Wang G et al. Frontiers in endocrinology (2024)
[77]
Parental fructose consumption induces early baroreflex dysfunction in offspring: impact on arterial pressure and on insulin resistance. — Dos Santos CP, Nascimento-Filho AVD, Araujo AA, da Silva Dias D, Silva DR, Bernardes N et al. International journal of obesity (2005) (2024)
[78]
Unsupervised identification of cardiometabolic profiles among adolescents: findings from the PARIS birth cohort study. — Lefebvre L, Grunemwald T, Hamrene K, Roda C, Momas I European journal of pediatrics (2024)
[79]
Beneficial associations between outdoor visible greenness at the workplace and metabolic syndrome in Chinese adults. — Pan J, Hu K, Yu X, Li W, Shen Y, Song Z et al. Environment international (2024)
[80]
Prospective bidirectional relations between depression and metabolic health: 30-year follow-up from the National Heart, Lung, and Blood Institute (NHLBI) Coronary Artery Disease in Young Adults (CARDIA) study. — Moorehead NR, Goodie JL, Krantz DS Health psychology : official journal of the Division of Health Psychology, American Psychological Association (2024)
[81]
Investigation of cardiovascular risk parameters in adolescents with metabolic syndrome. — Can U, Akdu S, Bağcı Z, Buyukinan M Cardiology in the young (2024)
[82]
Differences in vasomotor function of mesenteric arteries between Ossabaw minipigs with predisposition to metabolic syndrome and Göttingen minipigs. — Eickelmann C, Lieder HR, Sturek M, Heusch G, Kleinbongard P American journal of physiology. Heart and circulatory physiology (2024)
[83]
An Increase in Food Insecurity Correlated with an Increase in Plasma Triglycerides among Latinx Children. — Haushalter K, Burgermaster M, Hudson E, Landry MJ, Sharma SV, Davis JN The Journal of nutrition (2024)
[84]
Social and Environmental Determinants of Health and Cardio-Kidney-Metabolic Syndrome-Related Mortality. — Vieira de Oliveira Salerno PR, Cotton A, Elgudin YE, Virani S, Nasir K, Neeland I et al. JAMA network open (2024)
[85]
Cost Offset of Dapagliflozin in the US Medicare Population with Cardio-Kidney Metabolic Syndrome. — Chang RC, Miller RL, Kwon KW, Huang JC Advances in therapy (2024)
[86]
Lipid droplets in the endothelium: The missing link between metabolic syndrome and cardiovascular disease? — Jaffe IZ, Karumanchi SA The Journal of clinical investigation (2024)
[87]
The advent of RNA-based therapeutics for metabolic syndrome and associated conditions: a comprehensive review of the literature. — Huang HYR, Badar S, Said M, Shah S, Bharadwaj HR, Ramamoorthy K et al. Molecular biology reports (2024)
[88]
Ziziphus jujuba (Jujube) in Metabolic Syndrome: From Traditional Medicine to Scientific Validation. — Ghasemzadeh Rahbardar M, Fazeli Kakhki H, Hosseinzadeh H Current nutrition reports (2024)
[89]
Effects of telmisartan on metabolic syndrome components: a comprehensive review. — Imenshahidi M, Roohbakhsh A, Hosseinzadeh H Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (2024)
[90]
Triglyceride-glucose index is capable of identifying metabolically obese, normal-weight older individuals. — Kim B, Taniguchi K, Isobe T, Oh S Journal of physiological anthropology (2024)
[91]
Prevalence of metabolic syndrome and its association with CT-based central adiposity measures: a cross-sectional study at a tertiary care hospital in Pakistan. — Hussain Z, Habib A, Sajjad Z BMJ open (2024)
[92]
Metabolic disease remission after Roux-en-Y gastric bypass depends on preoperative disease severity: use of a new objective metabolic scoring system. — Wang A, Lyo V, Lew JC, Wong TL, Taylor SL, Akinjobi Z et al. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery (2024)
[93]
Association of volatile organic compound exposure with metabolic syndrome and its components: a nationwide cross-sectional study. — Dong R, Chang D, Shen C, Shen Y, Shen Z, Tian T et al. BMC public health (2024)
[94]
Muraqabah: Meaningful Adjuvant Therapy for Metabolic Health. — Ashraf H, Sheikh S, Rashid M, Kalra S JPMA. The Journal of the Pakistan Medical Association (2024)
[95]
Impact of age and gender differences in the prevalence and patterns of multimorbidity in the Thai Cohort Study. — Feng X, Sarma H, Seubsman SA, Sleigh A, Kelly M International health (2024)
[96]
Associations of multiple serum metals with the risk of metabolic syndrome among the older population in China based on a community study: A mediation role of peripheral blood cells. — Pang Y, Wang Y, Hao H, Zhu W, Zou M, Liu Q et al. Ecotoxicology and environmental safety (2024)
[97]
Ultra-processed food consumption and increased risk of metabolic syndrome in Korean adults: A cross-sectional analysis of the KNHANES 2016-2020. — Park H, Lee Y, Hwang J, Lee Y Nutrition (Burbank, Los Angeles County, Calif.) (2024)
[98]
Prevalence and secular trends in premetabolic syndrome in the United States: Findings from 1999-2020 nationally representative data of adults. — Amuda O, Okosun BO, Abdi H, Okosun IS Annals of epidemiology (2024)
[99]
Global burden of metabolic diseases, 1990-2021. — Zhang H, Zhou XD, Shapiro MD, Lip GYH, Tilg H, Valenti L et al. Metabolism: clinical and experimental (2024)
[100]
A dynamic probabilistic model of the onset and interaction of cardio-metabolic comorbidities on an ageing adult population. — Roversi C, Tavazzi E, Vettoretti M, Di Camillo B Scientific reports (2024)

Share:Twitter Reddit LinkedIn